Trinbelimab
Based on 1 Customer Validation
Trinbelimab (r-anti-D) is a recombinant anti-D immunoglobulin that targets the RhD antigen. Trinbelimab exerts immunosuppressive effects to block maternal-fetal RhD alloimmunization. Trinbelimab can be used for the study of maternal-fetal immunity associated with RhD incompatibility.
For research use only. We do not sell to patients.
- Purity : 99%
- CAS No.: 2415078-44-1
- Molecular Weight:145.47 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 lambda
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
RHD
In Vitro
Trinbelimab (r-anti-D) (300 mcg; in vitro) shows specific binding activity to RhD antigen on human red blood cells[1].
Trinbelimab exhibits comparable immunoreactivity to polyclonal anti-D against RhD-positive erythrocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 lambda
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2415078-44-1
-
Appearance Liquid
-
Molecular Weight 145.47 kDa
-
Color Colorless to light yellow
-
SMILES
[Trinbelimab]
-
Synonyms
r-anti-D
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)